TENOFOVIR DISOPROXIL + EMTRICITABINE

tenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30

TENOFOVIR DISOPROXIL + EMTRICITABINE (15410C)

tenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30
15410C
Body System:
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: Pre-exposure prophylaxis (PrEP) against human immunodeficiency virus (HIV) infection
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 60 # of repeats: 2 DPMQ: $56.08 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Tenofovir/Emtricitabine Sandoz 301/200